When was Acorn founded?

Acorn was founded in 2017 and raised its 1st funding round within a year of its incorporation.

Where is Acorn located?

Acorn is headquartered in Toronto, Canada.

Who is the current CEO of Acorn?

Drew Taylor of Acorn. They have also founded 1 company.

Is Acorn a funded company?

Acorn is a funded company, having raised a total of $3.33M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2017.

When was the latest funding round of Acorn?

Acorn's latest funding was a $***** Series A round on Jan 31, 2024, with participation from 0 investor.

Where does Acorn rank among its competitors?

Acorn ranks 2nd amongst 66 active competitors, of which 8 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Transcell, which secured $1.39M in Jul, 2024.

Who are the top competitors of Acorn?

Acorn's top competitors include StemCyte, Vita 34 and Forever Labs. Among them, Transcell secured the most recent funding round in July, 2024.

Acorn - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of stem cell biobanking services. The services include young cell preservation, non-invasive approaches, etc. This has applications in gene therapy, stem cell therapeutics, tissue engineering, organ regeneration, etc.

Website: acorn.me
Social
Email ID: *****@acorn.me, *****@acorn.me
Phone Number: +1 **********

Key Metrics

Founded Year

2017

Location

Toronto, Canada

Stage

Series A

Total Funding

$3.33M in 4 rounds

Latest Funding Round

Series A, Jan 31, 2024, $*****

Investors

Accelerator Centre & 6 more

Ranked

2^nd among 66 active competitors

Investment & Acquisitions

Vetic & 3 more

Similar Companies

StemCyte & 89 more

View Acorn's full profile

Acorn has raised a total funding of $3.33M over 4 rounds. Its first funding round was on 2017. Acorn has 7 institutional investors.

Here is the list of recent funding rounds of Acorn:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 31, 2024	7111296	Series A	8604897	7316625	8176786	1894679
Apr 02, 2019	4893054	Seed	9202929	6006958	4673988	5372586
Jan 16, 2019	2966875	Seed	9004105	9138456	2521014	Real Ventures & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Acorn's funding rounds and investors

The founders of Acorn are Laura Vaughan, Drew Taylor, Patrick Pumputis and Steven ten Holder. Drew Taylor is the CEO of Acorn.

Here are the details of Acorn's key team members:

Laura Vaughan: Cofounder, CTO of Acorn.
Drew Taylor: Co-Founder & CEO of Acorn.
Contact Info: 1 email address
Patrick Pumputis: Co-Founder & CSO of Acorn.
Steven ten Holder: Co-Founder & CIO of Acorn.

View details of Acorn's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Acorn include StemCyte, Vita 34 and Forever Labs. Here is the list of Top 10 competitors of Acorn, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	StemCyte 1997, Covina (United States), Public	Cord blood banking and regenerative therapeutics company focused on saving lives	$23.3M	penbank.com, Kenson Ventures & 7 others	54/100
2nd	Acorn 2017, Toronto (Canada), Series A	Provider of stem cell biobanking services	$3.33M	TELUS Ventures, Globalive Capital & 5 others	54/100
3rd	Vita 34 1997, Leipzig (Germany), Public	Provider of stem cell biobanking services	-	SHS, Elvaston Capital Management & 1 others	53/100
4th	Forever Labs 2015, Detroit (United States), Seed	Provider of stem cell storage and preservation services	$2.22M	FCVC, DTRIBE Capital & 11 others	50/100
5th	Transcell 2009, Hyderabad (India), Series A	Developer of stem cell therapies to treat cancer & rare diseases	$2.21M	Indian Angel Network, Quantiphi & 81 others	44/100
6th	China Cord Blood 2003, Hong Kong (China), Acquired	Provider of biobanking services for umbilical cord blood stem cells	-	KTB Network, DCP & 7 others	41/100
7th	Medeze Group 2016, Nakhon Pathom (Thailand), Public	Provider of stem cell technology and stem cell banking services	-	-	38/100
8th	LaCell 2010, New Orleans (United States), Funding Raised	Human-derived biomaterials and organ-on-a-chip models for preclinical drug development	-	National Science Foundation, HHS & 1 others	38/100
9th	Cryo-Cell 1989, Oldsmar (United States), Public	Provider of a cord blood bank to store stem cells	$2.9M	-	38/100
10th	Future Health Biobank 2002, Nottingham (United Kingdom), Unfunded	Provider of umbilical cord stem cell banking and genetic screening services	-	-	36/100